Contact Us
AI In Cancer Diagnostics Global Market Report 2025
Global AI In Cancer Diagnostics Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

AI In Cancer Diagnostics Global Market Report 2025

By Component (Software Solutions, Hardware, Services), By Cancer Type ( Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types), By Application (Screening And Diagnosis, Tumor Identification, Monitoring), By End User (Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

AI In Cancer Diagnostics Market Overview

• AI In Cancer Diagnostics market size has reached to $0.66 billion in 2024

• Expected to grow to $1.65 billion in 2029 at a compound annual growth rate (CAGR) of 20%

• Growth Driver: Rising Cancer Cases Propel Advances Artificial Intelligence Takes Center Stage In Cancer Diagnostics

• Market Trend: AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe

North America was the largest region in 2024.

What Is Covered Under AI In Cancer Diagnostics Market?

AI in cancer diagnostics refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to analyze medical images, genetic data, or patient histories to assist in the early detection, diagnosis, and prognosis of cancer. These systems can recognize patterns and anomalies in data that might be imperceptible to humans, increasing diagnostic accuracy and efficiency.

The main types of components of AI in cancer diagnostics are software solutions, hardware, and services. Software solutions refer to the use of artificial intelligence (AI) and machine learning (ML) technologies to improve the accuracy and efficiency of cancer detection, prognosis, and treatment selection. The various types of cancer include breast cancer, lung cancer, brain tumor, skin cancer and cervical cancer, prostate and colorectal cancer, and others. These are used in various applications such as screening and diagnosis, tumor identification, and monitoring and also by various end users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

AI In Cancer Diagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The AI In Cancer Diagnostics Market Size 2025 And Growth Rate?

The AI in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of AI applications beyond imaging.

What Is The AI In Cancer Diagnostics Market Growth Forecast?

The AI in cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to emergence of explainable AI, global increase in healthcare IT spending, integration with electronic health records (EHR), personalized medicine adoption, continued advances in AI algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology.

The forecast of 20.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of AI-powered histopathology scanners and genomic analysis software sourced from the UK and Canada, thereby slowing precision oncology adoption and elevating pathology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The AI In Cancer Diagnostics Market Segmented?

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations

Subsegments:

1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

What Is Driving The AI In Cancer Diagnostics Market? Rising Cancer Cases Propel Advances Artificial Intelligence Takes Center Stage In Cancer Diagnostics

The increasing prevalence of cancer is expected to propel the growth of artificial intelligence in the cancer diagnostics market going forward. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. The integration of AI in cancer care aims to enhance efficiency, accuracy, and personalized treatment options, ultimately improving outcomes for cancer patients. For instance, in May 2024, according to the National Cancer Institute, a US-based Government agency, In 2024, approximately 2 million new cancer cases are expected to be diagnosed in the U.S., with over 611,000 deaths projected. By 2040, new cancer cases are estimated to rise to 29.9 million globally, with cancer-related deaths increasing to 15.3 million. Therefore, the increasing prevalence of cancer is driving the growth of artificial intelligence in the cancer diagnostics market.

Who Are The Major Players In The Global AI In Cancer Diagnostics Market?

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

What Are The Key Trends Of The Global AI In Cancer Diagnostics Market? AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe

Major companies operating in the AI in cancer diagnostics market are experiencing significant growth due to advancements in AI-powered digital pathology solutions for cancer diagnosis. AI-powered digital pathology solutions for cancer diagnosis refer to the use of artificial intelligence (AI) algorithms to detect cancer and other diagnostic features in multiple tissue types, providing accurate and timely cancer diagnosis, support case prioritization, and reproducible diagnoses. For instance, In November 2023, Dedalus & Ibex Medical Analytics, a Europe-based health software company, launched an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to improve accuracy, provide AI-powered decision support tools, streamline reporting, enhance laboratory efficiency, and increase diagnostic confidence.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The AI In Cancer Diagnostics Market? Lunit Acquires Volpara Transforming AI Cancer Diagnostics

In December 2023, Lunit, a South Korean-based AI company, acquired Volpara for $193 million. This acquisition is expected to position the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market, due to Volpara's strong presence in over 2,000 medical sites across the U.S. and its extensive database of over 100 million high-quality mammogram images. The acquisition is contingent upon Volpara shareholders' and New Zealand High Court's approval. Volpara is a New Zealand-based company that provides AI-powered software for personalized screening and early detection of breast cancer.

What Is The Regional Outlook For The Global AI In Cancer Diagnostics Market?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the AI In Cancer Diagnostics Market?

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the AI In Cancer Diagnostics Industry?

The ai in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

AI In Cancer Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $0.79 billion
Revenue Forecast In 2034 $1.65 billion
Growth Rate CAGR of 20% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types
3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring
4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations Subsegments: 1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software
2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices
3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. AI In Cancer Diagnostics Market Characteristics

3. AI In Cancer Diagnostics Market Trends And Strategies

4. AI In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global AI In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global AI In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global AI In Cancer Diagnostics Market Growth Rate Analysis

5.4. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global AI In Cancer Diagnostics Total Addressable Market (TAM)

6. AI In Cancer Diagnostics Market Segmentation

6.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software Solutions

Hardware

Services

6.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Brain Tumor

Skin Cancer And Cervical Cancer

Prostate And Colorectal Cancer

Other Cancer Types

6.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Screening And Diagnosis

Tumor Identification

Monitoring

6.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Medical Research Institutes

Contract Research Organizations

6.5. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Machine Learning Software

Deep Learning Software

Image Analysis Software

6.6. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

AI-Powered Imaging Systems

Diagnostic Devices

6.7. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

AI Integration Services

Consulting And Training Services

Support And Maintenance Services

7. AI In Cancer Diagnostics Market Regional And Country Analysis

7.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Cancer Diagnostics Market

8.1. Asia-Pacific AI In Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Cancer Diagnostics Market

9.1. China AI In Cancer Diagnostics Market Overview

9.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Cancer Diagnostics Market

10.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Cancer Diagnostics Market

11.1. Japan AI In Cancer Diagnostics Market Overview

11.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Cancer Diagnostics Market

12.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Cancer Diagnostics Market

13.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Cancer Diagnostics Market

14.1. South Korea AI In Cancer Diagnostics Market Overview

14.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Cancer Diagnostics Market

15.1. Western Europe AI In Cancer Diagnostics Market Overview

15.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Cancer Diagnostics Market

16.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Cancer Diagnostics Market

17.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Cancer Diagnostics Market

18.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Cancer Diagnostics Market

19.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Cancer Diagnostics Market

20.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Cancer Diagnostics Market

21.1. Eastern Europe AI In Cancer Diagnostics Market Overview

21.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Cancer Diagnostics Market

22.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Cancer Diagnostics Market

23.1. North America AI In Cancer Diagnostics Market Overview

23.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Cancer Diagnostics Market

24.1. USA AI In Cancer Diagnostics Market Overview

24.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Cancer Diagnostics Market

25.1. Canada AI In Cancer Diagnostics Market Overview

25.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Cancer Diagnostics Market

26.1. South America AI In Cancer Diagnostics Market Overview

26.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Cancer Diagnostics Market

27.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Cancer Diagnostics Market

28.1. Middle East AI In Cancer Diagnostics Market Overview

28.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Cancer Diagnostics Market

29.1. Africa AI In Cancer Diagnostics Market Overview

29.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles

30.1. AI In Cancer Diagnostics Market Competitive Landscape

30.2. AI In Cancer Diagnostics Market Company Profiles

30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Tempus Overview, Products and Services, Strategy and Financial Analysis

31. AI In Cancer Diagnostics Market Other Major And Innovative Companies

31.1. Guardant Health

31.2. Lunit Inc.

31.3. Paige AI Inc.

31.4. Ada Health GmbH

31.5. Viz.ai Inc.

31.6. Butterfly Network Inc.

31.7. Insilico Medicine

31.8. BenevolentAI SA SA

31.9. Enlitic Inc.

31.10. Ibex Medical Analytics

31.11. Kheiron Medical Technologies Limited

31.12. CureMetrix Inc.

31.13. CancerIQ Inc.

31.14. MultiplAI Health

31.15. Freenome Holdings Inc.

32. Global AI In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

34. Recent Developments In The AI In Cancer Diagnostics Market

35. AI In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

35.1 AI In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 AI In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 AI In Cancer Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Microsoft Corporation Financial Performance
  • Table 79: IBM Corporation Financial Performance
  • Table 80: Babylon Healthcare Services Ltd. Financial Performance
  • Table 81: Verily Life Sciences LLC Financial Performance
  • Table 82: Tempus Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Microsoft Corporation Financial Performance
  • Figure 79: IBM Corporation Financial Performance
  • Figure 80: Babylon Healthcare Services Ltd. Financial Performance
  • Figure 81: Verily Life Sciences LLC Financial Performance
  • Figure 82: Tempus Financial Performance

Frequently Asked Questions

AI in cancer diagnostics refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to analyze medical images, genetic data, or patient histories to assist in the early detection, diagnosis, and prognosis of cancer. These systems can recognize patterns and anomalies in data that might be imperceptible to humans, increasing diagnostic accuracy and efficiency. For further insights on this market, request a sample here

The market major growth driver - Rising Cancer Cases Propel Advances Artificial Intelligence Takes Center Stage In Cancer Diagnostics. For further insights on this market, request a sample here

The ai in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of AI applications beyond imaging. The ai in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to " $1.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to emergence of explainable AI, global increase in healthcare it spending, integration with electronic health records (EHR), personalized medicine adoption, continued advances in AI algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology. For further insights on this market, request a sample here

The ai in cancer diagnosticsmarket covered in this report is segmented –
1) By Component: Software Solutions; Hardware; Services
2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types
3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring
4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations Subsegments:
1) By Software Solutions: Machine Learning Software; Deep Learning Software; Image Analysis Software
2) By Hardware: AI-Powered Imaging Systems; Diagnostic Devices
3) By Services: AI Integration Services; Consulting And Training Services; Support And Maintenance Services For further insights on this market,
request a sample here

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis. For further insights on this market, request a sample here.

Major trends in this market include AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon